Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis

PH Nguyen, A Ramamoorthy, BR Sahoo… - Chemical …, 2021 - ACS Publications
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …

[HTML][HTML] Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer's disease

F Kametani, M Hasegawa - Frontiers in neuroscience, 2018 - frontiersin.org
The so-called amyloid hypothesis, that the accumulation and deposition of oligomeric or
fibrillar amyloid β (Aβ) peptide is the primary cause of Alzheimer's disease (AD), has been …

Amyloid beta: structure, biology and structure-based therapeutic development

G Chen, T Xu, Y Yan, Y Zhou, Y Jiang… - Acta pharmacologica …, 2017 - nature.com
Amyloid beta peptide (Aβ) is produced through the proteolytic processing of a
transmembrane protein, amyloid precursor protein (APP), by β-and γ-secretases. Aβ …

[HTML][HTML] CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics

S Bhardwaj, KK Kesari, M Rachamalla, S Mani… - Journal of Advanced …, 2022 - Elsevier
Background Alzheimer's disease (AD) is an insidious, irreversible, and progressive
neurodegenerative health condition manifesting as cognitive deficits and amyloid beta (Aβ) …

The links between cardiovascular diseases and Alzheimer's disease

J Leszek, EV Mikhaylenko, DM Belousov… - Current …, 2021 - ingentaconnect.com
The root cause of non-inherited Alzheimer's disease (AD) remains unknown despite
hundreds of research studies performed to attempt to solve this problem. Since proper …

Crystal structure of the Frizzled 4 receptor in a ligand-free state

S Yang, Y Wu, TH Xu, PW de Waal, Y He, M Pu… - Nature, 2018 - nature.com
Frizzled receptors (FZDs) are class-F G-protein-coupled receptors (GPCRs) that function in
Wnt signalling and are essential for developing and adult organisms,. As central mediators …

Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?

F Checler, E Afram, R Pardossi-Piquard… - Journal of Biological …, 2021 - ASBMB
Genetic, biochemical, and anatomical grounds led to the proposal of the amyloid cascade
hypothesis centered on the accumulation of amyloid beta peptides (Aβ) to explain …

CRISPR-Cas9: A promising genome editing therapeutic tool for Alzheimer's disease—A narrative review

NC Barman, NM Khan, M Islam, Z Nain, RK Roy… - Neurology and …, 2020 - Springer
Alzheimer's disease (AD) is a chronic and irreversible neurodegenerative disorder
characterized by cognitive deficiency and development of amyloid-β (Aβ) plaques and …

Current druggable targets for therapeutic control of Alzheimer's disease

GL Gupta, NP Samant - Contemporary Clinical Trials, 2021 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative brain disorder that has an increasingly
large burden on health and social care systems. The pathophysiology involves the …

[HTML][HTML] Permissive Conformations of a Transmembrane Helix Allow Intramembrane Proteolysis by γ-Secretase

M Ortner, N Guschtschin-Schmidt, W Stelzer… - Journal of Molecular …, 2023 - Elsevier
The intramembrane protease γ-secretase activates important signaling molecules, such as
Notch receptors. It is still unclear, however, how different elements within the primary …